Blar i NTNU Open på forfatter "Haug, Erik Skaaheim"

Viser treff 1-7 av 7

    • Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival 

      Fosså, Sophie Dorothea; Aas, Kirsti; Muller, Christoph Rainer; Jerm, Marianne Brenn; Tandstad, Torgrim; Lilleby, Wolfgang; Kvåle, Rune; Gulbrandsen, Johanne; Haug, Erik Skaaheim; Myklebust, Tor Åge (Peer reviewed; Journal article, 2020)
      Background: More studies are needed to document nation-wide use and effectiveness of curative definitive radiotherapy (Def-RT) in the treatment of prostate cancer (PCa). Patients and methods: For 38,960 men diagnosed with ...

    • Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry 

      Haug, Erik Skaaheim; Myklebust, Tor Åge; Juliebø-Jones, Patrick; Reisæter, Lars Anders Rokne; Aas, Kirsti; Berg, Arne Stenrud; Muller, Christoph Rainer; Hofmann, Bjørn Morten; Størkersen, Øystein; Nilsen, Kim L.; Johannessen, Tom Børge; Beisland, Christian (Peer reviewed; Journal article, 2023)
      The aim of this study is to evaluate the 2015 introduction of prebiopsy magnetic resonance imaging of the prostate (MRI-P) as the standard of care for diagnosing prostate cancer (PCa) by the Norwegian public health care ...

    • Increased magnetic resonance imaging in prostate cancer management—What are the outcomes? 

      Hofmann, Bjørn Morten; Haug, Erik Skaaheim; Andersen, Eivind Richter; Kjelle, Elin (Peer reviewed; Journal article, 2022)
      Increased attention to cancer care has instigated altered systems for screening, diagnosis, and management of various types of cancer, such as in the prostate. While such systems very likely have improved the quality of ...

    • Infrarenal abdominal aortic aneurysm : comorbidity and results following open surgery 

      Haug, Erik Skaaheim (Doktoravhandlinger ved NTNU, 1503-8181; 2005:257, Doctoral thesis, 2005)

    • Predictors of upgrading from low-grade cancer at prostatectomy in men with biparametric magnetic resonance imaging 

      Christiansen, Ola; Bratt, Ola; Kirkevold, Øyvind; Saltyte Benth, Jurate; Manoharan, Pathmakulendran; Selnes, Anders; Haug, Erik Skaaheim; Jordhøy, Marit Slaaen (Peer reviewed; Journal article, 2022)
      Introduction: Prostate-specific antigen (PSA) density has previously been identified as a predictor of histological upgrading at radical prostatectomy, but how information from pre-treatment biparametric magnetic resonance ...

    • Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P) 

      Löffeler, Sven; Bertilsson, Helena Maria; Müller, Christoph Rainer; Aas, Kirsti; Haugnes, Hege Sagstuen; Aksnessæther, Bjørg Yksnøy; Pesonen, Maiju; Thon, Kristian; Tandstad, Torgrim; Murtola, Teemu; Poulsen, Mads Hvid Aaberg; Nordstrøm, Tobias; Vigmostad, Maria Nyre; Ottosson, Fredrik; Holmsten, Karin; Christiansen, Ola B.; Slaaen, Marit; Haug, Erik Skaaheim; Storås, Anne Holck; Asphaug, Lars; Rannikko, Antti; Brasso, Klaus (Peer reviewed; Journal article, 2024)
      Background Older men (aged ≥75 years) with high risk, non-metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs ...

    • T1 bladder cancer in Norway: treatment and survival 

      Blindheim, Augun Jodis; Fosså, Sophie Dorothea; Babigumira, Ronnie; Myklebust, Tor Åge; Haug, Erik Skaaheim; Arum, Carl-Jørgen; Kulle, Bettina (Peer reviewed; Journal article, 2020)
      Aim: Evaluation of treatment and survival of pT1 stage (T1) bladder cancer (BC) patients diagnosed with transitional cell carcinoma of the urinary bladder in Norway. Material and methods: According to the Cancer Registry ...